CD45 Rekombinanter Antikörper
CD45 Rekombinant Antikörper für IF/ICC, FC
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
IF/ICC, FC
Konjugation
Unkonjugiert
CloneNo.
241670E10
Kat-Nr. : 98117-1-RR
Synonyme
Geprüfte Anwendungen
| Erfolgreiche Detektion in IF/ICC | Jurkat-Zellen |
| Erfolgreiche Detektion in FC | human peripheral blood leukocytes |
Empfohlene Verdünnung
| Anwendung | Verdünnung |
|---|---|
| Immunfluoreszenz (IF)/ICC | IF/ICC : 1:125-1:500 |
| This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Produktinformation
98117-1-RR bindet in IF/ICC, FC CD45 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Rekombinant |
| Typ | Antikörper |
| Immunogen | CD45 fusion protein Eg2486 |
| Vollständiger Name | protein tyrosine phosphatase, receptor type, C |
| Berechnetes Molekulargewicht | 147 kDa |
| Gene symbol | CD45 |
| Gene ID (NCBI) | 5788 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein A purfication |
| Lagerungspuffer | PBS with 0.09% sodium azide |
| Lagerungsbedingungen | Store at 2 - 8°C. Stable for one year after shipment. |
Hintergrundinformationen
CD45, also known as protein tyrosine phosphatase, receptor type C, is a type I transmembrane protein expressed on the surface of all haematopoietic cells with the exception of erythrocytes and platelets (PMID: 3489673; 28615666). CD45 is a pan-haematopoietic cell marker and has been shown to be essential for T- and B-cell activation and signalling (PMID: 9429890; 16378097).
Protokolle
| PRODUKTSPEZIFISCHE PROTOKOLLE | |
|---|---|
| IF protocol for CD45 antibody 98117-1-RR | Protokoll herunterladen |
| FC protocol for CD45 antibody 98117-1-RR | Download protocol |
| STANDARD-PROTOKOLLE | |
|---|---|
| Klicken Sie hier, um unsere Standardprotokolle anzuzeigen |



